Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Pharmaceutical is a major Chinese pharmaceutical manufacturer with GMP-certified facilities producing antibiotics and other small molecule drugs. It holds hundreds of drug approvals in China, with several national brand generics such as acetylspiramycin tablets, amoxicillin capsules, rifampicin capsules, penicillin sodium for injection, ceftriaxone sodium for injection, cefotaxime sodium for injection, and ampicillin sodium for injection. The company has conducted multiple clinical trials focused on bioequivalence studies comparing its generic formulations to reference products like azithromycin dry suspension and vonoprazan fumarate tablets. Its approved pipeline includes oxacillin sodium targeting PBPs for staphylococcal infections and penicillamine targeting copper ions for Wilson’s disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Proud Era Pharmaceutical.